Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Arch Intern Med ; 157(1): 47-56, 1997 Jan 13.
Artigo em Inglês | MEDLINE | ID: mdl-8996040

RESUMO

BACKGROUND: The hospital discharge decision directly influences the length of stay in patients with community-acquired pneumonia, yet no information exists on how physicians make this decision. OBJECTIVES: To identify the factors physicians considered the factors responsible for extending length of hospital stay in clinically stable patients, and the outpatient medical services that would allow earlier hospital discharge for patients with community-acquired pneumonia. METHODS: Physicians responsible for the hospital discharge decision of patients with community-acquired pneumonia were asked to identify the factors responsible for extending stay in patients hospitalized beyond stability, and the medical services that could have allowed earlier hospital discharge to occur. RESULTS: For the 418 eligible patients with community-acquired pneumonia identified during the study, 332 questionnaires (79%) were completed by 168 physicians. Physicians believed 71 patients (22%) were discharged from the hospital 1 day or more (median, 2.5 days) after reaching clinical stability. The most common factors rated as being "very important" in delaying discharge were diagnostic evaluation or treatment of comorbid illness (56%), completion of a "standard course" of antimicrobials (15%), and delays with arrangements for long-term care (14%). Among the 302 patients with available information on both length of hospital stay and stability at discharge, median length of stay was 7.0 days for the 29 low-risk patients hospitalized beyond reaching clinical stability and 5.0 days for the remaining 128 low-risk patients (P < .005); median length of stay was 12.5 days for the 42 medium- and high-risk patients hospitalized beyond reaching clinical stability and 8.0 days in the remaining 113 medium- and high-risk patients (P < .001). Frequently cited medical services that "probably" or "definitely" would have allowed earlier discharge to occur included availability of home intravenous antimicrobial infusion (26%) and home visits by nurses (20%). CONCLUSIONS: Physicians believed that diagnostic evaluation or treatment of comorbid illness, completion of a standard course of antimicrobial therapy, and delays with arrangements for long-term care delayed hospital discharge in clinically stable patients. Addressing the efficiency of these aspects of inpatient medical care, as well as providing home treatment programs, could decrease the length of hospital stay in patients with community-acquired pneumonia.


Assuntos
Tomada de Decisões , Alta do Paciente , Pneumonia , Adulto , Idoso , Infecções Comunitárias Adquiridas , Feminino , Humanos , Tempo de Internação , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Risco , Fatores de Risco , Inquéritos e Questionários
2.
Zentralbl Chir ; 122(10): 909-13, 1997.
Artigo em Inglês | MEDLINE | ID: mdl-9401117

RESUMO

To get more information about the high infection rate in splenectomized adult patients 211 spleenless patients were investigated with regard to clinical and laboratory data and compared to healthy blood donors. The results show that the infection rate is markedly increased to 30%. Splenectomized patients have decreased IgG levels which is due to diminished IgG1 and IgG4. Whereas IgA, complement factors C3, C4, and transferrin are not changed in patients without spleen, fibronectin and IgM are significantly reduced and the phagocytosis as well as the migration of neutrophilic granulocytes is impaired to 50%. With these changes in laboratory data it is possible to identify patients which bear an increased risk with regard to infection.


Assuntos
Infecções Oportunistas/imunologia , Complicações Pós-Operatórias/imunologia , Esplenectomia , Infecção da Ferida Cirúrgica/imunologia , Adulto , Complemento C3/metabolismo , Complemento C4/metabolismo , Feminino , Humanos , Deficiência de IgG/imunologia , Imunoglobulinas/sangue , Masculino , Pessoa de Meia-Idade , Fatores de Risco , Transferrina/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA